News for Kyverna Therapeutics Inc Stock (KYTX)

Gainey McKenna & Egleston Announces A Class Action Lawsuit Has Been Filed Against Kyverna Therapeutics, Inc. (KYTX)

GlobeNewsWire • 12/10/24

KYTX SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Kyverna Therapeutics, Inc. Stockholders with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!

Accesswire • 12/10/24

SHAREHOLDER ALERT: Class Action Lawsuit Filed on Behalf of Kyverna Therapeutics, Inc. (KYTX) Investors – Holzer & Holzer, LLC Encourages Investors With Significant Losses to Contact the Firm

GlobeNewsWire • 12/10/24

Kyverna Therapeutics Sued for Securities Fraud; Investors Should Contact Block & Leviton to Learn How They Might Recover Losses

Accesswire • 12/10/24

Kyverna Therapeutics, Inc. Investors Who Have Lost Money Should Contact Block & Leviton to Find Out How They Might Recover Money Through A Recent Securities Lawsuit

GlobeNewsWire • 12/09/24

Scott+Scott Attorneys at Law LLP Files Securities Class Action Against Kyverna Therapeutics, Inc. (NASDAQ: KYTX)

Business Wire • 12/09/24

Kyverna Therapeutics Announces New Patient Data Highlighting Potential of KYV-101 for Treatment of Lupus Nephritis in Symposium at ACR Convergence 2024

PRNewsWire • 11/14/24

Kyverna Therapeutics Provides Business Update and Reports Third Quarter 2024 Financial Results

PRNewsWire • 11/13/24

Kyverna Therapeutics Appoints Mert Aktar to its Board of Directors

PRNewsWire • 10/21/24

Kyverna Therapeutics Presents Patient Data Reinforcing Potential of KYV-101 for Treatment of Neuroinflammatory Diseases in Symposium at ECTRIMS 2024

PRNewsWire • 09/18/24

Kyverna Therapeutics Announces Leadership Update

PRNewsWire • 09/16/24

Kyverna Therapeutics, Inc. May Have Committed Securities Fraud And The Schall Law Firm Encourages Shareholders To Join An Inquiry

Accesswire • 09/11/24

The Schall Law Firm Is Looking Into Whether Kyverna Therapeutics Inc Violated Securities Laws And Investors Are Invited To Participate

Accesswire • 09/10/24

Shareholders With Losses In Kyverna Therapeutics, Inc. Should Contact The Schall Law Firm About A Securities Fraud Investigation

Accesswire • 09/09/24

Kyverna Therapeutics Inc May Have Violated Securities Regulations And The Schall Law Firm Invites Investors To Join An Inquiry

Accesswire • 09/07/24

Shareholders In Kyverna Therapeutics, Inc. Are Urged To Partake In The Schall Law Firm's Securities Related Investigation

Accesswire • 09/06/24

The Schall Law Firm Is Looking Into Whether Kyverna Therapeutics Inc Committed Securities Fraud And Investors Should Join The Inquiry

Accesswire • 09/05/24

Kyverna Therapeutics Inc. May Have Violated Securities Regulations And The Schall Law Firm Wants Stakeholders With Losses To Reach Out

Accesswire • 09/04/24

The Schall Law Firm Is Looking Into Whether Kyverna Therapeutics Inc Committed Securities Fraud And Impacted Investors Are Urged To Play A Part

Accesswire • 09/03/24

Load Up on Adobe Stock and These 2 Others This September, J.P. Morgan Says

Barrons • 09/03/24

Kyverna Therapeutics Inc. May Be Liable To Compensate Investors And Those With Losses Should Contact The Schall Law Firm About An Inquiry

Accesswire • 09/02/24

The Schall Law Firm Wants The Public's Contributions To An Investigation Into Whether Kyverna Therapeutics Inc Committed Securities Fraud

Accesswire • 09/01/24

Kyverna Therapeutics Inc. Is Being Looked Into For Committing Securities Law Infractions And Stakeholders Are Invited To Help The Schall Law Firm

Accesswire • 08/31/24

A Securities Fraud Inquiry Has Been Launched Into Kyverna Therapeutics Inc And The Schall Law Firm Is Seeking Investor Participation

Accesswire • 08/30/24

The Schall Law Firm Is Investigating Whether Kyverna Therapeutics Inc. Violated Securities Laws And Shareholders Are Urged To Reach Out

Accesswire • 08/29/24